Verona Pharma plc Verona Pharma Plc : Total Voting Rights

 
TIDMVRP 
 
 
   October 2, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) 
("Verona Pharma"), in conformity with DTR 5.6 of the FCA's Disclosure 
and Transparency Rules, notifies the market that as at 30 September 
2017, the issued ordinary share capital of the Company consisted of 
105,017,401 ordinary shares with voting rights attached (one vote per 
ordinary share). There are no ordinary shares held in treasury. 
 
   The above total voting rights figure may be used by shareholders as the 
denominator for the calculations by which they will determine whether 
they are required to notify their interest in, or a change to their 
interest in, the Company under the FCA's Disclosure and Transparency 
Rules. 
 
   For further information, please contact: 
 
   Verona Pharma plc 
 
   Tel: +44 (0)20 3283 4200 
 
   Jan-Anders Karlsson, Chief Executive Officer 
 
   info@veronapharma.com 
 
   Stifel Nicolaus Europe Limited (Nominated Adviser and UK Broker) 
 
   Stewart Wallace / Jonathan Senior / Ben Maddison 
 
   Tel: +44 (0) 20 7710 7600 
 
   SNELVeronaPharma@stifel.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Verona Pharma plc via Globenewswire 
 
 
  http://www.veronapharma.com/

(END) Dow Jones Newswires

October 02, 2017 02:00 ET (06:00 GMT)

Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024